Is the Aviva share price undervalued?
Despite the insurer’s share price losing more than 20% of its value over the last five years, the stock continues to pay decent dividends and analysts remain positive about its prospects over the medium-term.
Aviva has seen its share price slowly decline over the last five years, with the stock losing more than 20% of its value in that time.
However, the British insurer remains a safe stock for investors, with it providing reliable and progressive dividends, yielding 8% returns for shareholders in 2018 and forecast to deliver 7.4% this year.
But is the Aviva share price undervalued? Analysts certainly think so.
Analysts upbeat about Aviva’s share price trajectory
The 18 analysts offering 12-month price targets for Aviva have a median target of 490p, with a high estimate of 575p and a low estimate of 420p, according to data compiled by the Financial Times.
Based on the company’s share price closing at 414.50p, the median estimate represents a potential upside of 18%, while the high and low targets imply the stock could increase by between 1.4% to 38%.
Aviva’s share price has also outperformed the FTSE 100 throughout November, trading around 3% higher than the blue-chip index.
Aviva opts to keep Singapore unit and JV in China
Following a strategic review of its operations in Singapore, which included potentially offloading the unit, Aviva has opted to retain the business, the company said on Monday.
‘Aviva can also confirm that its joint venture in China will be retained, given the scale of the market, excellent relationship with its partner COFCO and the high growth prospects,' Aviva added.
However, the insurer did say that it continues to explore strategic options for its operations in Hong Kong, Vietnam and Indonesia.
Aviva will unveil its full-year results on 5 March 2020.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets